137 related articles for article (PubMed ID: 27373314)
1. Promotion of epithelial-mesenchymal transition by Frizzled2 is involved in the metastasis of endometrial cancer.
Bian Y; Chang X; Liao Y; Wang J; Li Y; Wang K; Wan X
Oncol Rep; 2016 Aug; 36(2):803-10. PubMed ID: 27373314
[TBL] [Abstract][Full Text] [Related]
2. A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis.
Gujral TS; Chan M; Peshkin L; Sorger PK; Kirschner MW; MacBeath G
Cell; 2014 Nov; 159(4):844-56. PubMed ID: 25417160
[TBL] [Abstract][Full Text] [Related]
3. Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma.
Asano T; Yamada S; Fuchs BC; Takami H; Hayashi M; Sugimoto H; Fujii T; Tanabe KK; Kodera Y
Int J Oncol; 2017 May; 50(5):1647-1654. PubMed ID: 28350091
[TBL] [Abstract][Full Text] [Related]
4. Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling.
Nath D; Li X; Mondragon C; Post D; Chen M; White JR; Hryniewicz-Jankowska A; Caza T; Kuznetsov VA; Hehnly H; Jamaspishvili T; Berman DM; Zhang F; Kung SHY; Fazli L; Gleave ME; Bratslavsky G; Pandolfi PP; Kotula L
Cell Commun Signal; 2019 Sep; 17(1):120. PubMed ID: 31530281
[TBL] [Abstract][Full Text] [Related]
5. Frizzled2 mediates the migration and invasion of human oral squamous cell carcinoma cells through the regulation of the signal transducer and activator of transcription-3 signaling pathway.
Zhang E; Li Z; Xu Z; Duan W; Sun C; Lu L
Oncol Rep; 2015 Dec; 34(6):3061-7. PubMed ID: 26398330
[TBL] [Abstract][Full Text] [Related]
6. Fzd2 Contributes to Breast Cancer Cell Mesenchymal-Like Stemness and Drug Resistance.
Yin P; Wang W; Gao J; Bai Y; Wang Z; Na L; Sun Y; Zhao C
Oncol Res; 2020 May; 28(3):273-284. PubMed ID: 31907106
[TBL] [Abstract][Full Text] [Related]
7. Pan-cancer analysis of the developmental pathways reveals non-canonical wnt signaling as a driver of mesenchymal-type tumors.
Xue AG; Chan M; Gujral TS
Transl Res; 2020 Oct; 224():1-15. PubMed ID: 32522670
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of homeodomain-interacting protein kinase-2 contributes to bladder cancer metastasis by regulating Wnt signaling.
Tan M; Gong H; Zeng Y; Tao L; Wang J; Jiang J; Xu D; Bao E; Qiu J; Liu Z
J Cell Biochem; 2014 Oct; 115(10):1762-7. PubMed ID: 24824041
[TBL] [Abstract][Full Text] [Related]
9. Enolase-1 is a therapeutic target in endometrial carcinoma.
Zhao M; Fang W; Wang Y; Guo S; Shu L; Wang L; Chen Y; Fu Q; Liu Y; Hua S; Fan Y; Liu Y; Deng X; Luo R; Mei Z; Jiang Q; Liu Z
Oncotarget; 2015 Jun; 6(17):15610-27. PubMed ID: 25951350
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma.
Bao W; Qiu H; Yang T; Luo X; Zhang H; Wan X
PLoS One; 2013; 8(7):e70616. PubMed ID: 23936232
[TBL] [Abstract][Full Text] [Related]
11. Ectopic repression of receptor tyrosine kinase-like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial-mesenchymal transition.
Xu Y; Ma YH; Pang YX; Zhao Z; Lu JJ; Mao HL; Liu PS
Tumour Biol; 2017 May; 39(5):1010428317701627. PubMed ID: 28475014
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of SLCO4C1 inhibits cell proliferation and metastasis in endometrial cancer through inactivating the PI3K/Akt signaling pathway.
Hu X; Han T; Bian Y; Tong H; Wen X; Li Y; Wan X
Oncol Rep; 2020 Mar; 43(3):919-929. PubMed ID: 32020231
[TBL] [Abstract][Full Text] [Related]
13. Cancer-Associated Fibroblasts Induce Epithelial-Mesenchymal Transition in Endometrial Cancer Cells by Regulating Pituitary Tumor Transforming Gene.
Wang X; Sun X; Mu L; Chen W
Cancer Invest; 2019; 37(3):134-143. PubMed ID: 30961403
[TBL] [Abstract][Full Text] [Related]
14. FZD2 inhibits the cell growth and migration of salivary adenoid cystic carcinomas.
Ding LC; Huang XY; Zheng FF; Xie J; She L; Feng Y; Su BH; Zheng DL; Lu YG
Oncol Rep; 2016 Feb; 35(2):1006-12. PubMed ID: 25695658
[TBL] [Abstract][Full Text] [Related]
15. ALPL regulates the aggressive potential of high grade serous ovarian cancer cells via a non-canonical WNT pathway.
Luo M; Zhou L; Zhan SJ; Cheng LJ; Li RN; Wang H; Liu B; Linghu H
Biochem Biophys Res Commun; 2019 May; 513(2):528-533. PubMed ID: 30979497
[TBL] [Abstract][Full Text] [Related]
16. Autocrine motility factor promotes epithelial-mesenchymal transition in endometrial cancer via MAPK signaling pathway.
Li Y; Che Q; Bian Y; Zhou Q; Jiang F; Tong H; Ke J; Wang K; Wan XP
Int J Oncol; 2015 Sep; 47(3):1017-24. PubMed ID: 26201353
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of Sam68 expression in endometrial carcinoma.
Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
[TBL] [Abstract][Full Text] [Related]
18. BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10.
Gong C; Qu S; Lv XB; Liu B; Tan W; Nie Y; Su F; Liu Q; Yao H; Song E
Nat Commun; 2014 Nov; 5():5406. PubMed ID: 25406648
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the role of Frizzled 2 in different cancer types.
Zhou M; Sun X; Zhu Y
FEBS Open Bio; 2021 Apr; 11(4):1195-1208. PubMed ID: 33565732
[TBL] [Abstract][Full Text] [Related]
20. Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering with β-catenin-dependent and β-catenin-independent signaling pathways.
Zins K; Schäfer R; Paulus P; Dobler S; Fakhari N; Sioud M; Aharinejad S; Abraham D
Oncotarget; 2016 Jul; 7(29):46187-46202. PubMed ID: 27323822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
